Skip to Content


In the US, Daunorubicin (daunorubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Acute Lymphocytic Leukemia, Acute Myeloid Leukemia and Acute Nonlymphocytic Leukemia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent: Cytotoxic antibacterial from the group of anthracyclines

Chemical Names

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metyloxy-6,11-dioxo-naphtacen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (BAN)

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metyloxy-6,11-dioxo-naphtacenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (WHO)

(1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-metyloxy-6,11-dioxo--1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranoside (IUPAC)

Foreign Names

Generic Names

  • Daunorubicin (OS: BAN)
  • Daunorubicina (OS: DCIT)
  • Daunorubicine (OS: DCF)
  • Daunomycin (IS)
  • DNR (IS)
  • FI 6339 (IS)
  • NSC 82151 (IS)
  • RP 13057 (IS)
  • Rubidomycin (IS)
  • Daunorubicin, liposomal (IS)
  • Daunorubicin Hydrochloride (OS: USAN, BANM, JAN)
  • NDC 0082-4155 (IS)
  • Daunorubicin hydrochloride (PH: Ph. Eur. 8)
  • Daunorubicin Hydrochloride (PH: BP 2016, JP XVI, USP 38)
  • Daunorubicine (chlorhydrate de) (PH: Ph. Eur. 8)
  • Daunorubicinhydrochlorid (PH: Ph. Eur. 8)
  • Daunorubicini hydrochloridum (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.